New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research: Hereditary mutation drives aggressive head and neck, lung cancers in Asian population

Research: Hereditary mutation drives aggressive head and neck, lung cancers in Asian population

byNational University of SingaporeResearchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have uncovered a genetic variant in a g
World medicine December 09,2023
Research: Hereditary mutation drives aggressive head and neck, lung cancers in Asian population

Research: Hereditary mutation drives aggressive head and neck, lung cancers in Asian population

byNational University of SingaporeResearchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have uncovered a genetic variant in a g
World medicine December 09,2023
Insights into the diagnosis and treatment brain cancer in children

Insights into the diagnosis and treatment brain cancer in children

byKanazawa UniversityDeletion of the TPR gene led to lower levels of TPR and its associated protein HSF1 (left; lower panel) whereas rapamycin treatment reduced the tumor cells (dark blue cells)
World medicine December 09,2023
Insights into the diagnosis and treatment brain cancer in children

Insights into the diagnosis and treatment brain cancer in children

byKanazawa UniversityDeletion of the TPR gene led to lower levels of TPR and its associated protein HSF1 (left; lower panel) whereas rapamycin treatment reduced the tumor cells (dark blue cells)
World medicine December 09,2023
Low muscle mass, density linked to shorter survival in lymphoma

Low muscle mass, density linked to shorter survival in lymphoma

(HealthDay)—The combination of low muscle mass (LMM) and low muscle density (LMD) is associated with shorter survival in patients with diffuse large B-cell lymphoma (DLBCL), according to a study publi
World medicine December 09,2023
Low muscle mass, density linked to shorter survival in lymphoma

Low muscle mass, density linked to shorter survival in lymphoma

(HealthDay)—The combination of low muscle mass (LMM) and low muscle density (LMD) is associated with shorter survival in patients with diffuse large B-cell lymphoma (DLBCL), according to a study publi
World medicine December 09,2023
Racial differences seen for cancer diagnosis, treatment, survival

Racial differences seen for cancer diagnosis, treatment, survival

(HealthDay)—Stage at diagnosis, treatment, and survival differ by race and ethnicity for patients with one of the nine leading cancers, according to a study published online April 8 inJAMA Netwo
World medicine December 09,2023
Racial differences seen for cancer diagnosis, treatment, survival

Racial differences seen for cancer diagnosis, treatment, survival

(HealthDay)—Stage at diagnosis, treatment, and survival differ by race and ethnicity for patients with one of the nine leading cancers, according to a study published online April 8 inJAMA Netwo
World medicine December 09,2023
Racial disparity in prostate cancer survival tied to region

Racial disparity in prostate cancer survival tied to region

(HealthDay)—National, race-based differences in prostate cancer survival are due to regional variation, even for low-risk prostate cancer, according to a study published online March 31 inJAMA N
World medicine December 09,2023
Racial disparity in prostate cancer survival tied to region

Racial disparity in prostate cancer survival tied to region

(HealthDay)—National, race-based differences in prostate cancer survival are due to regional variation, even for low-risk prostate cancer, according to a study published online March 31 inJAMA N
World medicine December 09,2023
Radiation drugs with longer shelf life bring hope for cancer patients globally

Radiation drugs with longer shelf life bring hope for cancer patients globally

byUniversity of MelbourneMelbourne researchers are working with industry to increase the shelf-life of radiation drugs. Credit: IMCRCPeople with hard-to-reach cancers in the kidney, gut and pros
World medicine December 09,2023
Radiation drugs with longer shelf life bring hope for cancer patients globally

Radiation drugs with longer shelf life bring hope for cancer patients globally

byUniversity of MelbourneMelbourne researchers are working with industry to increase the shelf-life of radiation drugs. Credit: IMCRCPeople with hard-to-reach cancers in the kidney, gut and pros
World medicine December 09,2023
Blood test detects wide range of cancers, available to at risk individuals in clinical study

Blood test detects wide range of cancers, available to at risk individuals in clinical study

byDana-Farber Cancer InstituteCell-free DNA is isolated from blood samples drawn from a patient without cancer (top) or with cancer (bottom), and subjected to a targeted methylation sequencing a
World medicine December 09,2023
Blood test detects wide range of cancers, available to at risk individuals in clinical study

Blood test detects wide range of cancers, available to at risk individuals in clinical study

byDana-Farber Cancer InstituteCell-free DNA is isolated from blood samples drawn from a patient without cancer (top) or with cancer (bottom), and subjected to a targeted methylation sequencing a
World medicine December 09,2023
Loss of protein disturbs intestinal homeostasis and can drive cancer

Loss of protein disturbs intestinal homeostasis and can drive cancer

byUniversity of ZurichThe protein MCL1 (red dots) within the small intestine of a healthy mouse. The nuclei of individual cells (blue) are also visible. Credit: Marc Healy, UZHAn international t
World medicine December 09,2023
Loss of protein disturbs intestinal homeostasis and can drive cancer

Loss of protein disturbs intestinal homeostasis and can drive cancer

byUniversity of ZurichThe protein MCL1 (red dots) within the small intestine of a healthy mouse. The nuclei of individual cells (blue) are also visible. Credit: Marc Healy, UZHAn international t
World medicine December 09,2023
Chemo ups disease-free survival in upper tract urothelial cancer

Chemo ups disease-free survival in upper tract urothelial cancer

(HealthDay)—For patients with locally advanced upper tract urothelial carcinoma (UTUC), gemcitabine-platinum combination chemotherapy improves disease-free survival, according to a study published onl
World medicine December 09,2023
Chemo ups disease-free survival in upper tract urothelial cancer

Chemo ups disease-free survival in upper tract urothelial cancer

(HealthDay)—For patients with locally advanced upper tract urothelial carcinoma (UTUC), gemcitabine-platinum combination chemotherapy improves disease-free survival, according to a study published onl
World medicine December 09,2023
Finding the weak points of cancer cells

Finding the weak points of cancer cells

by Tokyo Metropolitan Institute of Medical ScienceIn both p53-defiencient and -positive cancer cells (HeLa [Human Cervix Epitheloid Carcinoma] and U2OS [Human Osteosarcoma], respectively), Cdc7 deplet
World medicine December 09,2023
Finding the weak points of cancer cells

Finding the weak points of cancer cells

by Tokyo Metropolitan Institute of Medical ScienceIn both p53-defiencient and -positive cancer cells (HeLa [Human Cervix Epitheloid Carcinoma] and U2OS [Human Osteosarcoma], respectively), Cdc7 deplet
World medicine December 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com